Spagnol G, Marchetti M, Carollo M, Bigardi S, Tripepi M, Facchetti E
Cancers (Basel). 2024; 16(22).
PMID: 39594745
PMC: 11592863.
DOI: 10.3390/cancers16223790.
LeBien J, Velev J, Roche-Lima A
Sci Rep. 2024; 14(1):19332.
PMID: 39164433
PMC: 11336095.
DOI: 10.1038/s41598-024-70074-6.
Landolfo C, Ceusters J, Valentin L, Froyman W, Van Gorp T, Heremans R
Br J Cancer. 2024; 130(6):934-940.
PMID: 38243011
PMC: 10951363.
DOI: 10.1038/s41416-024-02578-x.
Trinidad C, Pathak H, Cheng S, Tzeng S, Madan R, Sardiu M
Sci Rep. 2023; 13(1):18341.
PMID: 37884576
PMC: 10603107.
DOI: 10.1038/s41598-023-44050-5.
Keum J, Lee W, Choi J, Bae J, Cho S, Kang B
J Pers Med. 2023; 13(8).
PMID: 37623476
PMC: 10455920.
DOI: 10.3390/jpm13081226.
CA125 Levels in BRCA mutation carriers - a retrospective single center cohort study.
Gebhart P, Singer C, Gschwantler-Kaulich D
BMC Cancer. 2023; 23(1):610.
PMID: 37393265
PMC: 10315033.
DOI: 10.1186/s12885-023-11116-6.
Effect of Serum Level of Human Epididymis Protein 4 and Interleukin-6 as Biomarkers in Patients with Adnexal Mass.
Hameed S, Abdulqader Jasim H, Sharief M
Arch Razi Inst. 2023; 77(5):1659-1671.
PMID: 37123162
PMC: 10133630.
DOI: 10.22092/ARI.2022.358329.2194.
Insight on Non-Coding RNAs from Biofluids in Ovarian Tumors.
Dabi Y, Favier A, Razakamanantsoa L, Delbos L, Poilblanc M, Descamps P
Cancers (Basel). 2023; 15(5).
PMID: 36900328
PMC: 10001105.
DOI: 10.3390/cancers15051539.
Surveillance of gynecologic cancer patients post-COVID-19 vaccine: Are CA-125 levels reliable?.
Thayer E, Walsh L, Leung K, Korets S
Gynecol Oncol Rep. 2023; 45:101140.
PMID: 36714374
PMC: 9859765.
DOI: 10.1016/j.gore.2023.101140.
Defining Models to Classify between Benign and Malignant Adnexal Masses Using Routine Laboratory Parameters.
Reiser E, Pils D, Grimm C, Hoffmann I, Polterauer S, Kranawetter M
Cancers (Basel). 2022; 14(13).
PMID: 35804981
PMC: 9264825.
DOI: 10.3390/cancers14133210.
Transient rise in CA 125 in a woman with ovarian carcinoma and COVID-19 infection.
Smith M, Lara O, Pothuri B
Gynecol Oncol Rep. 2020; 34:100644.
PMID: 32964093
PMC: 7497776.
DOI: 10.1016/j.gore.2020.100644.
Comparison of Risk of Ovarian Malignancy Algorithm and cancer antigen 125 to discriminate between benign ovarian tumor and early-stage ovarian cancer according to imaging tumor subtypes.
Lee Y, Kim Y, Kang J, Nam S, Kim D, Kim Y
Oncol Lett. 2020; 20(1):931-938.
PMID: 32566022
PMC: 7285867.
DOI: 10.3892/ol.2020.11629.
Reducing Ovarian Cancer Mortality Through Early Detection: Approaches Using Circulating Biomarkers.
Trinidad C, Tetlow A, Bantis L, Godwin A
Cancer Prev Res (Phila). 2020; 13(3):241-252.
PMID: 32132118
PMC: 7080297.
DOI: 10.1158/1940-6207.CAPR-19-0184.
Elevated CA-125 in IgG4 mesenteritis: a red herring or a disease biomarker? Case report and literature review.
Michaud Maturana M, Panayotidis I, Psarelis S, Nakos G, Nikiphorou E
Rheumatol Int. 2018; 39(7):1285-1289.
PMID: 30143819
DOI: 10.1007/s00296-018-4145-7.
Pelvic Tuberculosis Diagnosed during Operative Laparoscopy for Suspected Ovarian Cancer.
Martingano D, Cagle-Colon K, Chiaffarano J, Marcus A, Contreras D
Case Rep Obstet Gynecol. 2018; 2018:6452721.
PMID: 29850317
PMC: 5925173.
DOI: 10.1155/2018/6452721.
Black pleural effusion due to pancreatic pseudocyst: A case report.
Guo F, Wu J, Peng Y, Tu M, Xiao B, Dai C
Medicine (Baltimore). 2018; 96(50):e9043.
PMID: 29390299
PMC: 5815711.
DOI: 10.1097/MD.0000000000009043.
Development of a tool for prediction of ovarian cancer in patients with adnexal masses: Value of plasma fibrinogen.
Seebacher V, Aust S, DAndrea D, Grimm C, Reiser E, Tiringer D
PLoS One. 2017; 12(8):e0182383.
PMID: 28837575
PMC: 5570374.
DOI: 10.1371/journal.pone.0182383.
Circulating biomarkers in epithelial ovarian cancer diagnosis: from present to future perspective.
Montagnana M, Benati M, Danese E
Ann Transl Med. 2017; 5(13):276.
PMID: 28758102
PMC: 5515813.
DOI: 10.21037/atm.2017.05.13.
Validation of a Novel Biomarker Panel for the Detection of Ovarian Cancer.
Leung F, Bernardini M, Brown M, Zheng Y, Molina R, Bast Jr R
Cancer Epidemiol Biomarkers Prev. 2016; 25(9):1333-40.
PMID: 27448593
PMC: 5010461.
DOI: 10.1158/1055-9965.EPI-15-1299.
Prognostic Value of Circulating Tumor Cells in Ovarian Cancer: A Meta-Analysis.
Zhou Y, Bian B, Yuan X, Xie G, Ma Y, Shen L
PLoS One. 2015; 10(6):e0130873.
PMID: 26098665
PMC: 4476582.
DOI: 10.1371/journal.pone.0130873.
